Browsing by Author McShane, H
Showing results 4 to 16 of 16
< previous
Issue Date | Title | Author(s) |
---|---|---|
14-Dec-2018 | Human Hookworm Infection Enhances Mycobacterial Growth Inhibition and Associates With Reduced Risk of Tuberculosis Infection | O'Shea, MK; Fletcher, TE; Muller, J; Tanner, R; Matsumiya, M; Bailey, JW; Jones, J; Smith, SG; Koh, G; Horsnell, WG; Beeching, NJ; Dunbar, J; Wilson, D; Cunningham, AF; McShane, H |
2009 | Identification of major factors influencing ELISpot-based monitoring of cellular responses to antigens from mycobacterium tuberculosis | Smith, SG; Joosten, SA; Verscheure, V; Pathan, AA; McShane, H; Ottenhoff, THM; Dockrell, HM; Mascart, F |
27-Sep-2018 | Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection | O’Shea, MK; Tanner, R; Müller, J; Harris, SA; Wright, D; Stockdale, L; Stylianou, E; Satti, I; Smith, SG; Dunbar, J; Fletcher, TE; Dedicoat, M; Cunningham, AF; McShane, H |
5-Jan-2022 | Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination | Bitencourt, J; Peralta-Álvarez, MP; Wilkie, M; Jacobs, A; Wright, D; Salman Almujri, S; Li, S; Harris, SA; Smith, SG; Elias, SC; White, AD; Satti, I; Sharpe, SS; O’Shea, MK; McShane, H; Tanner, R |
31-Jan-2019 | Optimisation, harmonisation and standardisation of the direct mycobacterial growth inhibition assay using cryopreserved human peripheral blood mononuclear cells | Tanner, R; Smith, SG; van Meijgaarden, KE; Giannoni, F; Wilkie, M; Gabriele, L; Palma, C; Dockrell, HM; Ottenhoff, THM; McShane, H |
2011 | A phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults | Minassian, AM; Rowland, R; Beveridge, NE; Poulton, ID; Satti, I; Harris, S; Poyntz, H; Hamill, M; Griffiths, K; Sander, CR; Ambrozak, DR; Price, DA; Hill, BJ; Casazza, JP; Douek, DC; Koup, RA; Roederer, M; Winston, A; Ross, J; Sherrard, J; Rooney, G; Williams, N; Lawrie, AM; Fletcher, HA; Pathan, AA; McShane, H |
2017 | Predicting IFN-γ responses after BCG vaccination in humans from macaques: A proof-of-concept study of Immunostimulation/Immunodynamic modelling methods | Rhodes, SJ; Sarfas, C; Knight, GM; White, A; Pathan, AA; McShane, H; Evans, TG; Fletcher, H; Sharpe, S; White, RG |
2012 | A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity | Rowland, R; Brittain, N; Poulton, ID; Minassian, AM; Sander, C; Porter, DW; Satti, I; Pathan, AA; Lawrie, AM; McShane, H; Williams, N |
2013 | Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A | Matsumiya, M; Stylianou, E; Griffiths, K; Lang, Z; Meyer, J; Harris, SA; Rowland, R; Minassian, AM; Pathan, AA; Fletcher, H; McShane, H |
2009 | Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in mycobacterium tuberculosis–infected individuals | Sander, CR; Pathan, AA; Beveridge, NER; Poulton, I; Minassian, A; Alder, N; Van Wijgerden, J; Hill, AVS; Gleeson, FV; Davies, RJO; Pasvol, G; McShane, H |
2009 | Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: Comparison with boosting with a new TB vaccine, MVA85A | Whelan, KT; Pathan, AA; Sander, CR; Fletcher, HA; Poulton, I; Alder, NC; Hill, AVS; McShane, H |
2014 | Serum indoleamine 2,3-dioxygenase activity is associated with reduced immunogenicity following vaccination with MVA85A. | Tanner, R; Kakalacheva, K; Miller, E; Pathan, AA; Chalk, R; Sander, CR; Scriba, T; Tameris, M; Hawkridge, T; Mahomed, H; Hussey, G; Hanekom, W; Checkley, A; McShane, H; Fletcher, HA |
2011 | Th1/Th17 Cell Induction and Corresponding Reduction in ATP Consumption following Vaccination with the Novel Mycobacterium tuberculosis Vaccine MVA85A | Griffiths, KL; Pathan, AA; Minassian, AM; Sander, CR; Beveridge, NER; Hill, AVS; Fletcher, HA; McShane, H |